Related Experiment Videos
Reduced pupillary reward sensitivity in Parkinson's disease
1Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
NPJ Parkinson'S Disease
|March 31, 2017
Summary
Parkinson's disease (PD) patients exhibit reduced autonomic responses to rewards, impacting motivation. Dopaminergic medication can restore this reward sensitivity, suggesting a key role for dopamine in PD nonmotor symptoms.
Area of Science:
- Neuroscience
- Psychology
Background:
- Nonmotor symptoms in Parkinson's disease (PD) are linked to reward processing abnormalities.
- Dopaminergic pathway dysfunction may alter incentive motivation in PD.
Purpose of the Study:
- To investigate reward processing and autonomic responses in Parkinson's disease patients ON and OFF dopaminergic medication.
- To determine if dopaminergic drugs can restore reward sensitivity in PD.
Main Methods:
- Studied 16 Parkinson's disease patients and healthy controls performing a speeded saccade task with monetary incentives.
- Manipulated reward availability using auditory incentive precues.
- Measured pupil dilatation as an index of autonomic response to incentives.
Main Results:
- Parkinson's disease patients showed diminished autonomic responses to incentives compared to controls.
- Dopaminergic medication significantly increased pupil responses to reward in PD patients.
- Autonomic reward processing deficits in PD are responsive to dopaminergic therapy.
Conclusions:
- Blunted autonomic responses to incentives are characteristic of Parkinson's disease.
- Dopaminergic medication can modulate and potentially restore reward sensitivity in PD.
- Reward processing deficits may contribute to nonmotor manifestations of Parkinson's disease.